Streaming issues? Report here
John Maytham 2019 1500 BW John Maytham 2019 1500 BW
Afternoon Drive with John Maytham
15:00 - 18:00
volume_up
volume_mute

Up Next: The Money Show with Bruce Whitfield
See full line-up
Afternoon Drive with John Maytham
15:00 - 18:00
Home
arrow_forward
Business
fiber_manual_record
Opinion

Pfizer’s Covid-19 vaccine is extremely effective (90%)

9 November 2020 6:24 PM
Tags:
The Money Show
Medical Research Council
Bruce Whitfield
Pfizer
Glenda Gray
COVID-19
COVID-19 vaccine
Pfizer Covid-19 vaccine

Pfizer is on the verge of cracking a Covid-19 vaccine, says Dr Glenda Gray, CEO at Medical Research Council.

Pfizer’s Covid-19 vaccine is 90% effective, according to data from its Phase-3 clinical trial involving 43 538 participants.

The World Health Organisation (WHO) recommends that successful vaccines should show a disease risk reduction of at least 50%.

© perutskyi/123rf.com

RELATED: Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson


Pfizer expects to supply 50 million doses of its vaccine this year and up to 1.3 billion in 2021.

The Money Show’s Bruce Whitfield interviewed Dr Glenda Gray, CEO at Medical Research Council.

Gray is, according to Forbes magazine, one of Africa’s most powerful women.

This is a wonderful outcome… incredibly exciting…

Dr Glenda Gray, CEO - Medical Research Council

It [Pfizer vaccine] needs two doses and requires enormous refrigerator capability…

Dr Glenda Gray, CEO - Medical Research Council

South Africa was involved in the Pfizer study…

Dr Glenda Gray, CEO - Medical Research Council

Everybody is tired of this pandemic… this is great news… We can start working on making it affordable, and available...

Dr Glenda Gray, CEO - Medical Research Council

Listen to the interview in the audio below.




9 November 2020 6:24 PM
Tags:
The Money Show
Medical Research Council
Bruce Whitfield
Pfizer
Glenda Gray
COVID-19
COVID-19 vaccine
Pfizer Covid-19 vaccine

More from Covid-19 coronavirus explained

More from Information about Covid-19 coronavirus